Biomarkers Market - What are the Short and long-term actions taken by Key Players During Coronavirus Pandemic ? - PowerPoint PPT Presentation

About This Presentation
Title:

Biomarkers Market - What are the Short and long-term actions taken by Key Players During Coronavirus Pandemic ?

Description:

Biomarkers Market Worth USD 97.51 Billion at 12.1% CAGR; Persistent Usage in Disease Diagnostics to Fuel Growth: Fortune Business Insights™ – PowerPoint PPT presentation

Number of Views:28

less

Transcript and Presenter's Notes

Title: Biomarkers Market - What are the Short and long-term actions taken by Key Players During Coronavirus Pandemic ?


1
Title Biomarkers Market to Reach USD 97.51
Billion by 2026 Biomarkers Market to Exhibit
12.1 CAGR by 2026 Description Biomarkers Market
Worth USD 97.51 Billion at 12.1 CAGR Persistent
Usage in Disease Diagnostics to Fuel Growth
Fortune Business Insights Content The global
biomarkers market is set to gain traction from
their increasing usage in a wide variety of
applications, namely, drug discovery and
development, safety assessment, and medicine.
Besides, numerous biotech and pharmaceutical
companies are persistently investing huge sums
in the research and development activities. The
increasing prevalence of cancer is also one of
the crucial factors that would affect the market
positively during the forecast period. The above
information is given by Fortune Business
Insights in a recent study, titled, Biomarkers
Market Size, Share Industry Analysis, By
Indication (Oncology, Cardiology, Neurology, and
Others), By End User (Pharmaceutical
Biotechnology Companies, Diagnostics Research
Laboratories, Hospitals Specialty Clinics, and
Others), and Regional Forecast, 2019-2026. The
study further mentions that the biomarker market
size was USD 39.10 billion in 2018 and is
projected to reach USD 97.51 billion by 2026,
thereby exhibiting a CAGR of 12.1 during the
forecast period. An Overview of the Impact of
COVID-19 on this Market The emergence of
COVID-19 has brought the world to a standstill.
We understand that this health crisis has
brought an unprecedented impact on businesses
across industries. However, this too shall pass.
Rising support from governments and several
companies can help in the fight against this
highly contagious disease. There are some
industries that are struggling and some are
thriving. Overall, almost every sector is
anticipated to be impacted by the pandemic. We
are taking continuous efforts to help your
business sustain and grow during COVID-19
pandemics. Based on our experience and expertise,
we will offer you an impact analysis of corona
virus outbreak across industries to help you
prepare for the future. Click here to get the
short-term and long-term impact of COVID-19 on
this Market. Please visit https//www.fortuneb
usinessinsights.com/biomarkers-market-102173
Drivers
2
Increasing Demand for Personalized Medicine to
Accelerate Growth Biomarkers are increasingly
used in disease diagnostics. They also play an
important role in development of personalized
medicine for several disease conditions. Disease
diagnosis and treatment procedures possess
certain limitations and because of this, the
concept of personalized medicine is becoming
popular nowadays. Patients suffering from
immunological disorders and cancer are rapidly
inclining towards customized treatment options
based on their genetic and clinical features. It
would propel the biomarkers market growth during
the forecast period. Regional Analysis- Rising
Investment by Key Players to Favor Growth in
North America The market is geographically
fragmented into Asia Pacific, North America,
Latin America, the Middle East and Africa, and
Europe. Out of these regions, in 2018, North
America held USD 14.80 billionbiomarkers market
revenue and is expected to grow by showcasing a
high CAGR in the coming years. This is likely to
occur because of the rising investments by
several industry giants in the development of
biomarkers. The region will be followed by
Europe. Asia Pacific, on the other hand, is
anticipated to grow with a higher CAGR owing to
the increasing demand for disease diagnosis
because of the rising incidence of cardiovascular
disease and cancer. As per the Ministry of
Health, approximately 203 million people are
living with cardiovascular diseases in Chinaat
present. It is set to upsurge by 73.0 in 2030.
It would in turn, drive the growth of the market
in this region. More Trending Topics from Fortune
Business Insights Europe Compression Bandages
Market Share, Growth, Sales and Drivers Analysis
Research Report 2026 Europe Compression
Bandages Market to Witness a Healthy CAGR of
5.2 Advent of Efficient Pressure Bandages to
Provide Impetus, says Fortune Business Insights
Write a Comment
User Comments (0)
About PowerShow.com